Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #d #pharma

Posted On Apr 21 2017 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #pharma #drugs

Posted On Dec 20 2016 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Why the party is over with Forest Pharmaceuticals, the makers of Armour – Stop The Thyroid Madness #history #of #pharmaceutical #industry

Posted On Dec 9 2016 by

#forrest pharma # Why the party is over with Forest Pharmaceuticals, the makers of Armour Janie wrote the following in 2009 about Armour, and wouldn t you know, 2015 sees another problem with Armour! In 2002, when I first got on natural desiccated thyroid and it absolutely changed my life. it happened to be the brand name called Armour by Forest Pharmaceuticals. You could do it sublingually (even if it wasn t made that way), and I praised Armour for that. So did other patients after we spread the word on patient groups, on the STTM website and in the …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #www.buy-pharma.com

Posted On Nov 23 2016 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #drug #manufacturer

Posted On Nov 6 2016 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Why the party is over with Forest Pharmaceuticals, the makers of Armour – Stop The Thyroid Madness #jobs #in #pharmaceuticals

Posted On Nov 3 2016 by

#forrest pharma # Why the party is over with Forest Pharmaceuticals, the makers of Armour Janie wrote the following in 2009 about Armour, and wouldn t you know, 2015 sees another problem with Armour! In 2002, when I first got on natural desiccated thyroid and it absolutely changed my life. it happened to be the brand name called Armour by Forest Pharmaceuticals. You could do it sublingually (even if it wasn t made that way), and I praised Armour for that. So did other patients after we spread the word on patient groups, on the STTM website and in the …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living #pharmajobs

Posted On Oct 28 2016 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …


Why the party is over with Forest Pharmaceuticals, the makers of Armour – Stop The Thyroid Madness

Posted On Sep 26 2016 by

#forrest pharma # Why the party is over with Forest Pharmaceuticals, the makers of Armour Janie wrote the following in 2009 about Armour, and wouldn t you know, 2015 sees another problem with Armour! In 2002, when I first got on natural desiccated thyroid and it absolutely changed my life. it happened to be the brand name called Armour by Forest Pharmaceuticals. You could do it sublingually (even if it wasn t made that way), and I praised Armour for that. So did other patients after we spread the word on patient groups, on the STTM website and in the …


Raptor Pharma to Stop Development of Liver Drug: Here – s Why: Healthy Living

Posted On Sep 19 2016 by

#raptor pharma # Raptor Pharma to Stop Development of Liver Drug: Here s Why Raptor Pharma announced that it will no longer pursue the development of its experimental drug RP103 as treatment for the liver disease Nonalcoholic steatohepatitis in children. (Photo. Bill Brooks | Flickr) Raptor Pharmaceutical Corporation is pulling the plug on an experimental drug as treatment for a liver disease. In a statement released on Monday, Sept.14, the biopharmaceutical company said that the drug called RP103 (cysteamine bitartrate) did not meet the main goals in the Phase 2b CyNCh study. The study, which involved 169 participants between 8 …